DUAL NOX4/NOX1 INHIBITION BY SETANAXIB HALTS CHOLANGIOCARCINOMA PROGRESSION BY IMPAIRING CANCER ASSOCIATED FIBROBLAST ACTIVATION

被引：0

作者：

Amengual, Josep ^{[1
,2
]}

Gonzalez-Sanchez, Ester ^{[1
,2
,3
,4
,5
]}

Fuste, Noel P. ^{[1
]}

Pons, Gabriel ^{[6
]}

Sererols-Vinas, Laura ^{[7
]}

Alay, Ania ^{[8
,9
]}

Hijazo-Pechero, Sara ^{[9
]}

Martin-Mur, Beatriz ^{[10
]}

Esteve-Codina, Anna ^{[10
]}

Ferrer, Joana ^{[2
,11
]}

Gores, Gregory J. ^{[12
]}

Ilyas, Sumera I. ^{[12
]}

Calvisi, Diego ^{[13
]}

Aoudjehane, Lynda ^{[14
,15
]}

Fouassier, Laura ^{[15
]}

Coulouarn, Cedric ^{[16
]}

Affo, Silvia ^{[7
]}

Fabregat, Isabel ^{[1
,2
]}

Vaquero, Javier ^{[1
,2
,4
,5
]}

机构：

[1] Bellvitge Biomed Res Inst IDIBELL, TGF & Canc Grp, Oncobell Program, Barcelona, Spain

[2] Inst Salud Carlos III, CIBEREHD, Natl Biomed Res Inst Liver & Gastrointestinal Dis, Madrid, Spain

[3] Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain

[4] Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca, Spain

[5] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca, Spain

[6] Univ Barcelona, Dept Physiol Sci, Barcelona, Spain

[7] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain

[8] Catalan Inst Oncol, Unit Bioinformat Precis Oncol, Barcelona, Spain

[9] IDIBELL, Preclin & Expt Res Thorac Tumors PReTT, Oncobell Program, Lhospitalet De Llobregat, Spain

[10] CNAG, Barcelona, Spain

[11] Univ Barcelona, Liver Unit, Barcelona Clin Liver Canc BCLC Grp, Hosp Clin Barcelona,IDIBAPS, Barcelona, Spain

[12] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA

[13] Univ Regensburg, Inst Pathol, Regensburg, Germany

[14] Sorbonne Univ, INSERM, Inst Cardiometab & Nutr ICAN, Paris, France

[15] Sorbonne Univ, INSERM, CRSA, Paris, France

[16] Univ Rennes, OSS, Ctr Lutte Canc Eugene Marquis, INSERM, Rennes, France

来源：

FREE RADICAL BIOLOGY AND MEDICINE | 2024年 / 218卷

关键词：

D O I：

10.1016/j.freeradbiomed.2024.04.160

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

PP II_C99

引用

页码：45 / 45

页数：1